Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC) - Van Cutsem, E; Kang, Y; Chung, H (Journal of Clinical Oncology, 2009)
et al.